MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Test-Retest Reliability of Sensor-Based Telemonitoring of Parkinsonian Gait at Home

    G. Rigas, N. Kostikis, N. Tachos, K. Tsamis, D. Kakalou, S. Konitsiotis, D. Fotiadis (Ioannina, Greece)

  • TET2-mediated Cdkn2A DNA hydroxymethylation in dopaminergic neuronal injury of Parkinson’s disease

    Y.C Wu, TT. Wu, X. Li, T. Liu (Shanghai, China)

  • Thalamic Deep Brain Stimulation for Acquired Dystonia in Children and Young Adults: A Phase I Clinical Trial

    M. San Luciano, A. Viehoever, I. Bledsoe, K. Dodenhoff, M. Gittings, A. Viser, C. Racine-Belkoura, C. Pereira, S. Wang, P. Starr, J. Ostrem (San Francisco, CA, USA)

  • Thalamic deep brain stimulation improves tremor and spatio-temporal characteristics of gait in medically refractory orthostatic tremor

    A. Giritharan, M. Mancini, S. Stuart, R. Morris, S. Anderson, J. Wilhelm, J. Nutt (Portland, OR, USA)

  • Thalamic nuclei volumes and intrinsic thalamic network in motor subtype in Parkinson’s disease

    J. Park, H.T Kim (Busan, Republic of Korea)

  • The ‘A’ in the A/T/N Alzheimer’s Disease Biomarker Classification Predicts Cognitive Outcomes in Parkinson’s Disease

    N. Han, D. Weintraub, L. Shaw, J. Trojanowski, A. Chen-Plotkin, T. Tropea (Philadelphia, PA, USA)

  • The Accreditation and Certification of the Movement Disorders Subspecialty: A Five-Year Follow-Up Study

    S. O'Shea, L. Gutmann, L. Faulkner (Boston, MA, USA)

  • The add-on effect of Lactobacillus plantarum PS128 in patients with Parkinson’s disease: A pilot study

    H.C Chang, Y.C Tsai, C.S Lu (Taoyuan City, Taiwan)

  • The ADNPC-RS: a risk score that identifies Lewy body disease individuals at risk for developing concomitant Alzheimer’s pathology

    D. Dai, T. Tropea, J. Robinson, E. Suh, H. Hurtig, D. Weintraub, V. Van Deerlin, E. Lee, J. Trojanowski, A. Chen-Plotkin (Philadelphia, PA, USA)

  • The association between thinning of cerebral cortex and age of onset in Parkinson’s disease

    K. Seo, R. Yokohama, Y. Ito, Y. Nakazato, I. Matunari, H. Matuda, T. Yamamoto (Saitama, Japan)

  • « Previous Page
  • 1
  • …
  • 128
  • 129
  • 130
  • 131
  • 132
  • …
  • 149
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Safety and Tolerability of a Ketone Supplement in Parkinson's Disease
  • Successful external defibrillation in a patient with bilateral deep brain stimulation
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley